换一批
换一批The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
作者：
关键词
Cl, confidence intervalDCR, disease control rateNHERF1/EBP50OR, odds ratioPD, progression diseasecHIF-1α, cytoplasmic HIF-1αcNHERF1, cytoplasmic NHERF1cP-gp, cytoplasmic P-gpcSR1, cytoplasmic SR1chemotherapygastric cancerimmunohistochemistrymP-gp, membranous P-gpmulti-drug resistancenHIF-1α, nuclear HIF-1αnNHERF1, nuclear NHERF1predictive factor
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞核(Cell Nucleus);抗药性, 肿瘤(Drug Resistance, Neoplasm);表柔比星(Epirubicin);女(雌)性(Female);人类(Humans);缺氧诱导因子1, α亚基(Hypoxia-Inducible Factor 1, alpha Subunit);男(雄)性(Male);中年人(Middle Aged);有机铂化合物(Organoplatinum Compounds);磷蛋白类(Phosphoproteins);参考值(Reference Values);回顾性研究(Retrospective Studies);胃肿瘤(Stomach Neoplasms);治疗结果(Treatment Outcome)
DOI
10.1080/15384047.2015.1056414
PMID
26126066
发布时间
2020-09-30
- 浏览43
Cancer biology & therapy
1140-7页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
